About Novo Nordisk India

Being a market leader in the space of diabetes care and haemophilia management creates the need to attract the best talent and also to maximise the potential of employees to enable them to achieve their career best. Diversity, inclusivity, equal opportunities and a healthy working environment are an integral part of our philosophy.

Novo Nordisk insulins have been present in India from 1935 marking more than 80 years of uninterrupted supply. The India arm started operations in 1992 with its headquarters in Bengaluru. We now have over 1.300 employees, and are the 5th largest and the one of the fastest growing pharmaceutical MNCs in India.


Our growth is your opportunity to create a life-changing career in an expanding organisation. Our best-in-class product portfolio and strong product pipeline create a dynamic working environment, where strong cross-functional collaboration is essential.


Our success depends on your dedication and eagerness to learn and grow with us. As we progress and grow, we will face new exciting challenges that will accelerate your development and advance your skills and career.


This is your opportunity to join a leading global company and make a difference to the lives of millions of people around the world.


Take the first steps now!
See current vacant positions and sign up for the email job alert to be notified of job opportunities matching your interest. Feel free to Contact us if you have any questions.



Novo Nordisk India
CIN : U24111KA1994PTCO15194

Plot No.32, 47-50,
EPIP Area, Whitefield,
Bangalore - 560 066
Telephone:
+91 80 4030 3200
Fax No.:
+91 80 4112 3518

Email HR: Contact us

Email - Other:
 Contact us

Email Job Alert
At Novo Nordisk India we are filling up to 300 jobs by 2020. Connect with us and stay updated with our latest job opportunities

Sign up now

Living with Diabetes
Millions of people today have diabetes or take care of someone with the disease. It is possible to lead a full and active life with diabetes when the disease is properly managed. Read more.


Join us and +600,000 followers and learn about our fight against diabetes